A national, targeted melanoma screening program for Australia is the goal of a University of Queensland-led project that aims to improve the early detection of potentially deadly skin cancers in patients in regional and rural Australia. Funded by $3 million from the Medical Research Future Fund, the project will investigate how 3D total body photography, combined with artificial intelligence tools for clinicians, can enhance and expedite skin cancer imaging.
Skin cancer rates are higher in regional areas, but less than 10 percent of dermatologists practice outside capital cities. This means that many regional Australians do not have equal access to skin imaging services and face longer wait times between detection and treatment, which can ultimately lead to loss of life. The aim of the project is to address these challenges by ensuring equal access to skin imaging services for all Australians, regardless of where they live.
The research will take place at 9 regional hospital and health care centres across Queensland, New South Wales and Victoria. A 3D total body imaging trial hub has been established in partnership with Mildura Base Public Hospital. New technologies, including AI in healthcare and minimally invasive biopsy methods, will be introduced at all 9 regional hubs to benefit from consumer feedback and shape the project’s focus.
Geographical isolation and limited access to healthcare facilities pose significant challenges for those living in regional Australia. However, the use of technology can help overcome these obstacles by providing remote access to medical expertise and improving communication between patients and healthcare providers.
The initiative is part of the ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis, which brings together researchers from UQ, Monash University, and the University of Sydney to improve research and clinical trial opportunities for patients in regional areas. With this collaboration, the project hopes to make a meaningful impact on melanoma diagnosis and treatment outcomes across Australia.